Ph.D., Co-Founder & CTO, Mammoth Biosciences
Biography
Janice Chen is the co-founder and CTO of Mammoth Biosciences, a biotechnology company harnessing the diversity of nature to power the next generation of CRISPR products across diagnostics and therapeutics. Through its discovery of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. Janice received her PhD from the lab of Nobel Laureate Professor Jennifer Doudna at University of California, Berkeley. She investigated mechanisms of CRISPR proteins and developed technologies leading to multiple papers and patents, and co-invented the programmable CRISPR-based detection technology called DETECTR. Janice was selected as a Forbes 30 Under 30 in Healthcare, Business Insider's 30 Under 40 in Healthcare, Endpoints Top 20 Women in Biopharma, MIT Technology Review 35 Innovators Under 35 and delivered a TEDx talk on the potential for CRISPR to democratize diagnostics.
Clinical Dx Showcase:
Mammoth Biosciences
Mammoth Biosciences is a biotechnology company harnessing a revolutionary gene-editing tool called CRISPR to deliver on the promise of precision medicine across diagnostics and therapeutics.
The Next-Generation CRISPR Applications Platform
The programmable nature of sequence-specific targeting by CRISPR-Cas nucleases has revolutionized a wide range of genomic applications and is now enabling next-generation diagnostics. This talk will explore the impact of CRISPR across a continuum of diagnostic applications.
